https://www.synconaltd.com/news-insights/news/ionctura-expands-roginolisib-trials-to-the-us-advancing-multi-indication-strategy-in-oncology/
iOnctura Expands Roginolisib Trials to the US, Advancing Multi-Indication Strategy in Oncology |...
iOnctura is a clinical-stage precision oncology company combating neglected and hard-to-treat cancers with a pipeline of first-in-class small molecules.
advancing multiioncturatrials
https://www.synconaltd.com/portfolio/clinical-companies/ionctura/
iOnctura | Clinical companies | Portfolio | Syncona
iOnctura is a clinical-stage oncology company developing innovative therapies for neglected and hard-to-treat cancers.
clinical companies portfolio